Tumor Masses, Tumor Doses, and Normal-Organ Doses for Patients with Pathologic Uptake
| Dose (mGy/MBq) | ||||||
| Patient no. | Tumors analyzed (n) | Tumor mass (g)* | Tumors† | Kidneys | Liver | Spleen |
| 1 | 3 | 139 (8–123) | 0.041 (0.031–0.047) | 0.024 | 0.014 | 0.030 |
| 3 | 7 | 85 (8–25) | 0.004 (0.003–0.005) | 0.012 | 0.011 | 0.015 |
| 10 | 1 | 17 | 0.005 | 0.023 | 0.015 | 0.039 |
| 17 | 2 | 1,455 (600–855) | 0.004 (0.003–0.005) | 0.023 | 0.014 | 0.037 |
| 19 | 3 | 249 (47–141) | 0.024 (0.022–0.028) | 0.023 | 0.012 | 0.034 |
| 21 | 1 | 23 | 0.013 | 0.033 | 0.014 | 0.025 |
| 22 | 1 | 122 | 0.018 | ND | ND | ND |
| 23 | 1 | 86 | 0.029 | 0.026 | 0.018 | 0.055 |
| 24 | 1 | 76 | 0.053 | 0.018 | 0.015 | 0.029 |
| 25 | 1 | 44 | 0.033 | 0.019 | 0.010 | 0.040 |
| 27 | 2 | 246 (70–176) | 0.006 (0.004–0.007) | ND | ND | ND |
| 28 | 1 | 7 | 0.016 | 0.013 | 0.010 | 0.024 |
* When more than 1 lesion was analyzed, total mass is listed, followed by range in parentheses.
† When more than 1 lesion was analyzed, average dose is listed, followed by range in parentheses.
ND = not determined when region fell outside SPECT field of view.